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a b s t r a c t
Alphatetraviruses are small (þ) ssRNA viruses with non-enveloped, icosahedral, T¼4 particles that
assemble from 240 copies of a single capsid protein precursor. This study is focused on the mechanisms
underlying selection and packaging of genomic vRNAs by Helicoverpa armigera stunt virus. We
demonstrate that the viral protein, p17, is packaged at low levels (between 4 and 8 copies per capsid)
raising the possibility of icosahedral asymmetry in wild-type particles. p17 promotes packaging of
vRNA2 by virus-like particles (VLPs) generated from plasmid-expressed vRNA2. The 50 and 30 UTRs of
RNA2 are not required for encapsidation. VLPs produced by recombinant baculoviruses package vRNA2
at detectable levels even in the absence of p17 and apparently excluding baculoviral transcripts. This
suggests a role for p17 in vRNA selectivity. This is one of few examples of the packaging of a minor non-
structural protein by (þ) ssRNA animal viruses.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Small, icosahedral RNA viruses typically have limited genomic
coding capacity because of restrictions dictated by their capsid size
and the constraints of RNA structure. Many viruses therefore have
evolved mechanisms such as ribosome recoding, overlapping open
reading frames (ORFs), multifunctional proteins and the assembly
of virions using repeating capsid protein(s) subunits to overcome
the constraints on genome size. Small RNA viruses also have to
ensure that they selectively package only their own viral RNA and
have thus developed specialized strategies that ensure the exclu-
sion of cellular RNAs during particle assembly.
Tetraviruses are among the simplest RNA viruses known,
encoding only a single capsid protein (CP) and RNA replicase on
one or two positive sense (þ), single-stranded (ss) genomic RNAs
(Dorrington and Short, 2010). The tetraviruses are classiﬁed into
three families based on the characteristics of their viral replicases:
the Alphatetraviridae, with alpha-like replicases, the Permutotetra-
viridae that have picorna-like replicases and the Carmotetraviridae,
with a carmo-like viral replicase (Dorrington et al., 2011; ICTV
Virus Taxonomy: 2011 release). Alphatetraviruses are further
classiﬁed according to their genome organization, packaging
either one (Genus: Betatetravirus) or two (Genus: Omegatetravirus)
genomic RNAs (gRNAs) in a non-enveloped capsid of approxi-
mately 40 nm in diameter (Dorrington et al., 2011). The omegate-
travirus RNA1 encodes the viral replicase while RNA2 encodes the
CP ORF and a second ORF, p17, the product of which is not required
for assembly of virus-like particles (VLPs) (Hanzlik et al., 1995).
All tetravirus capsids comprise 240 subunits of the CP in a T¼4
icosahedral arrangement, with each subunit undergoing autopro-
teolytic cleavage at its C-terminus during particle maturation
(Agrawal and Johnson, 1995; Canady et al., 2000). The CP of
permutotetraviruses and carmotetraviruses is also subject to co-
translational processing via the activity of 2A-like sites at the N-
terminus (Pringle et al., 1999, 2003). Each tetravirus capsid subunit
consists of three regions: (i) an internal helical domain, which
interacts with genomic RNA and forms the molecular switch that
determines the T¼4 architecture of the tetravirus capsid; (ii) a β-
barrel comprising the capsid shell and (iii) an external
immunoglobulin-like domain, proposed to function in receptor
binding during infection of host cells (Munshi et al., 1996;
Helgstrand et al., 2004). The mechanism of tetravirus capsid
assembly and maturation as well as pH-dependent molecular
dynamics have been well studied (Canady et al., 2000, 2001;
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Bothner et al., 2005; Matsui et al., 2009, 2010; Domitrovic et al.,
2012; Tang et al., 2014).
VLPs of the omegatetraviruses, Nudaurelia cythera capensis ω
virus (NωV) and Helicoverpa armigera stunt virus (HaSV) readily
self-assemble in insect and yeast cells expressing CP and are
structurally indistinguishable from the wild-type capsids (Agrawal
and Johnson, 1995 Canady et al., 2000; Tomasicchio et al., 2007).
NωV VLPs produced by recombinant baculoviruses expressing CP in
insect cells, package CP mRNA (Agrawal and Johnson, 1995).
However, other observations are that these VLPs do not speciﬁcally
encapsidate viral RNAs and contain mostly cellular RNAs as well as
some mRNA expressing the capsid protein precursor (Canady et al.,
2000; Maree et al., 2006; Taylor, 2003). Next generation sequencing
analysis of the contents of NωV VLPs demonstrated that of a total of
23.3 Mb of sequence data obtained, approx. 80% was of ribosomal
origin, 12% corresponded to mRNAs from the baculoviral vector and
the CP mRNA comprised only 5% of the packaged RNA (Routh et al.,
2012). The packaging proﬁle of NωV VLPs was similar to that of
VLPs derived from Flock House virus (FHV), a member of the
structurally-related Nodaviridae family (Thiéry et al., 2011).
The p17 ORF, which is unique to the omegatetraviruses, is
located upstream of and overlapping with the CP ORF on RNA2
and is conserved in all three known omegatetraviruses, NωV, HaSV
and Dendrolimus punctatus tetravirus (DpTV), producing a protein
with a predicted molecular weight of 17 kDa (du Plessis et al.,
2005; Hanzlik et al., 1995; Yi et al., 2005). All three predicted p17
translation products contain an unusually high proportion of
proline, glutamate, serine and threonine (PEST) amino acids, a
characteristic of transcription factors and cell cycle regulators that
are subject to high turnover rates (Salaman et al., 1994;
Reichsteiner and Rogers, 1996). It has been proposed that p17
might have a regulatory function in the virus lifecycle as a viral
movement protein (Hanzlik et al., 1995), while in vitro binding
studies with recombinant DpTV p17 have led to speculation that
p17 may be involved in viral RNA replication (Zhou et al., 2008).
Alternatively, the location of the p17 ORF so close to that of CP
suggests that there may be functional links between the two
proteins.
In this study, we initially determined that p17 is expressed
during infection and thereafter investigated the co-packaging of
p17 during capsid assembly, testing the hypothesis that the
protein may function as a selectivity factor during RNA2 encapsi-
dation. We report that p17 is expressed at low levels in HaSV-
infected H. armigera midgut tissue and is packaged by wild-type
virus particles. Our data shows that p17 promotes viral RNA2
packaging when the viral RNA concentration is limiting and that
sequences present in the 50 and 30 UTRs of RNA2 are not required
for this effect. In contrast, VLPs derived from recombinant
baculovirus-driven expression package viral RNA2 even in the
absence of p17, potentially excluding non-viral, baculoviral RNAs.
Results
HaSV p17 is packaged inside wild-type HaSV particles
The p17 ORF is present on the omegatetravirus RNA2 upstream
of and overlapping with the CP ORF in all three omegatetraviruses.
Their position and high degree of sequence conservation (Fig. 1)
suggests that the expression and function of p17 and CP might be
linked. First we investigated whether p17 was expressed in the
midgut cells of HaSV-infected larvae. Western analysis with anti-
p17 antiserum detected a protein migrating at approximately
24 kDa in cell-free extracts derived from virus-infected H. armigera
midgut tissue (Fig. 2A, lane 3), which was presumed to be p17
since this band was absent in uninfected midgut cell-tree extracts
(Fig. 2A, lane 4). The p17 detected in midgut tissue of HaSV-
infected H. armigera larvae migrated at a slightly higher molecular
weight relative to recombinant his-tagged p17 (Fig. 2A, lane 3 vs.
5). This result is in agreement with previous analysis of the
products of in vitro translation of RNA2 (Hanzlik et al., 1995).
Expression of p17 was signiﬁcantly lower compared to that of the
(mature) virus capsid protein (p64), which could be detected by
Coomassie staining (Fig. 2A, lane 1).
Western analyses of wild-type HaSV particles detected p17, but
only when at least 2 μg of virus was used (Fig. 2B) and, as observed
in cell-free extracts from infected insect midgut tissue, native
p17 migrated at a higher MR than his-tagged p17 (Fig. 2B). To
address the question of whether p17 is packaged inside the virus
particle as opposed to being a co-puriﬁed contaminant, a dissocia-
tion study was performed using 4 M guanindine hydrogen chlor-
ide (GdnHCl), which is often used to dissociate both speciﬁc and
Fig. 1. Alignment of the three omegatetravirus p17 protein coding sequences. The alignment was done using the Clustal Omega software and shows identical amino acid
residues (n) and functionally conserved amino acids (:). Potential PEST sequences (boxed) were determined using PEST-ﬁnd (EMBOSS) with a window size of 10, with scores
of 7.4 (HaSV H36–K70), 9.77 (DpTV R70–K83) and 15.14 (DpTV R120–R137). Potential ubiquitylation sites (bold and boxed in black) were predicted using the UBPred
software (Radivojac et al., 2010), identifying one site in HasV (K70) with a high probability (score of 0.84) and two sites with medium probability in NωV (K62, K145)) with
scores of 0.76 and 0.83, respectively. GenBank accession numbers for RNA2 sequences: NC_001982 (HaSV), DQ054400 (NωV) and AY594353 (DpTV).
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non-speciﬁc protein-protein interactions. Incubation with 4 M
GdnHCl would result in the removal of p17 proteins from the
surface of virus particles but not if they are packaged inside the
particle. First Dynamic Light Scattering (DLS) was used to examine
the dissociation resistance of fully matured, wild-type HaSV
particles to 4 M GdnHCl. Puriﬁed wild-type HaSV particles were
incubated in buffer containing 4 M GdnHCl for at least 6 h
followed by buffer exchange and concentration using a 100 kDa
cut-off ﬁlter to remove dissociated proteins. The DLS results
showed that both the hydrodynamic radius and polydispersity
were slightly increased by the addition of GdnHCl (Table 1).
However regardless of the presence or absence of GdnHCl, the
sizes were consistent with an assembled particle. Since maturation
results in increased stability of tetravirus particles (Matsui et al.,
2010), we concluded that the GdnHCl treatment did not result in
virus particle disassembly. Western analysis detected the presence
of p17 in both untreated and GdnHCl-treated virus particles
(Fig. 2C) leading us to conclude that p17 is packaged inside wild-
type HaSV particles. Based on the relative intensity of Western blot
signals (Fig. 2B), we estimate that between 10 and 20 ng of p17
was detected in 2.4 μg of wild-type virus particles. Taking into
account the relative mass of p17 vs. CP (p71) this would equate to
between 4 and 8 copies of p17 per virus particle. However, the
need to overload virus samples to detect p17 would affect the
resolving capacity of the SDS-polyacrylamide gels and therefore
our estimate of p17 copy number will need to be reﬁned.
Regulation of p17 expression
Having compared the levels of p17 relative to CP in infected
larvae, we investigated why p17 is present at such low levels even
though it is the ORF closest to the 50 end of RNA2. Several potential
factors could explain the down-regulation of HaSV p17 expression
including a poor translation context (Kozak sequence) relative to
the consensus sequence for invertebrates (Table 2), which is also
the case for NωV and DpTV. Bioinformatic analysis identiﬁed
features that might be involved in regulating p17 protein turnover.
These include potential PEST domains in the HaSV (H36-K70) and
DpTV p17 (R70-K83 and R120-R137) coding sequences and puta-
tive ubiquitylation sites, one with a high probability (K70) in the
HaSV p17 CDS, just within the potential PEST sequence, and two
with medium probability (K62, K145) in NωV p17 (Fig. 1). The
absence of identiﬁable PEST domains and ubiquitylation sites in
NωV and DpTV, respectively, suggest that the most likely reason
for the low p17 levels is related to the poor translation initiation
context.
The effect of the translation initiation sequence on p17 expres-
sion was investigated in plasmid-transfected Spodoptera frugiperda
(Sf9) cells, focussing on the poor translational context of the AUG
start of p17 (AUUUAUGA) vs. that of p71 (CAGGAUGG) and
compared with the consensus for invertebrates, CAAAAUGA
(Cavener, 1987). First, p17 was expressed in its native translation
context in RNA2 (i.e. overlapping with p71), using two different
promoters to support low (PAcMNPV) or high (Phr:AcMNPV) levels of
transcription. Expression plasmids pMV17 (PAcMNPV) and pMV18
(Phr:AcMNPV) contain the full-length 50 UTR found in the native HaSV
RNA2, while pMV19 (PAcMNPV) and pMV20 (Phr:AcMNPV) express p17
and p71 from a truncated 50 UTR (Table 2). A signiﬁcant amount of
Fig. 2. Expression of and packaging of p17 in wild-type HaSV particles.
(A) Expression of p17 in HaSV-infected H. armigera midgut tissue. Crude protein
was extracted from 300 mg of midgut tissue from infected (þ) and uninfected
() H. armigera larvae, resolved by SDS-PAGE and stained with Coomassie Blue
(Lanes 1–2). The band representing the mature CP β subunit (p64) is indicated with
an arrow. The presence of p17 in uninfected () or HaSV-infected (þ) H. armigera
larval midgut tissue (Lanes 3 and 4) was determined by western analysis using
anti-p17 polyclonal antibodies. (B) Detection of p17 in wild-type virus particles.
Left: Wild-type HaSV (2.4 μg) resolved by SDS-PAGE and stained with Coomassie
Blue Right: Western analysis using anti-p17 antibodies of wild-type (wt) HaSV
(2.4 μg) and 6xhis-tagged p17 (20 ng). (C) Detection of p17 in wild-type HaSV
particles treated with guanidine hydrochloride (GdnHCl). Left: Coomassie-stained
SDS-polyacrylamide gel with 100 ng each of untreated wild-type HaSV (HaSV wt)
and HaSV treated with GdnHCl. Right Western analysis to detect p17 in HaSV
particles after treatment with 4 M GdnHCl. Approx. 2.5 mg of HaSV was used for the
western analysis.
Table 1
Dynamic light scattering (DLS) analysis in the presence or absence of guanidine
hydrochloride.
Sample Rh (nm) % Pd % Int % Mass
HaSV 22.2 9.6 100 100
HaSVþ 4 M GdnHCl 24.2 10.2 100 100
Abbreviations: Hydrodynamic radius (Rh); percentage of polydispersity (% Pd);
relative amount of light scattered by the population (% Int); estimated relative
amount of mass (% Mass); guanidime hydrochloride (GdnHCl).
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the CP precursor (p71), with lower levels of mature CP (p64), was
detected in cells transfected with all four constructs, while no CP
was detected in cells transfected with pMV21, carrying only the
p17 ORF (Fig. 3A). A small increase in p71 expression was observed
in cells transfected with the plasmids containing the truncated
leader sequence (pMV19 and pMV20) compared to the plasmids
pMV17 and pMV18 (full RNA2 50 UTR sequence), but the two
promoters had little effect on the expression of p71 (Fig. 3A). No
protein corresponding to p17 was detected when the native
translation initiation context was used (Fig. 3A). Since p17 and
p71 are transcribed from a polycistronic mRNA and p71 was
efﬁciently expressed, we attribute the lack of detectable p17 to
post-transcriptional regulation of expression due to its poor
translational start and regulatory elements in the 50 UTR sequence
(increased p71 expression with a truncated 50 UTR in pMV20).
The effect of a truncated 50 UTR and/or an optimized Kozak
sequence on p17 expression, was investigated using pMV18 and
pMV20 (native viral Kozak with a full length versus truncated 50
UTR) as well as pMV25 (no viral 50 UTR and native Kozak) and
pMV24 which has no viral 50 UTR and a Kozak optimized for
invertebrates (Table 2). p17 was detected in cells transfected with
pMV24 (Fig. 3B, lane 4) but little if any was detected in cells
expressing p17 with its native Kozak, irrespective of the length or
nature of the leader sequence (Fig. 3B, lane 5 and lanes 1–3). Thus
the poor native viral Kozak sequence is likely the major reason for
low levels of p17 expression observed in S. frugiperda cells and in
the midgut cells of HaSV-infected larvae.
p17 and packaging of vRNA2 under RNA-limiting conditions
There have been several reports that VLPs assembled in insect
cells expressing only the NωV CP (p70) coding sequence package
predominantly cellular RNAs (Canady et al., 2000; Taylor 2003;
Maree et al., 2006; Routh et al., 2012) but others have observed
packaging of CP mRNA by NωV VLPs (Agrawal and Johnson, 1995).
The latter study used a cDNA sequence that begins at nt 274 of
NωV RNA2, four nucleotides upstream of the AUG start of the p17
ORF, likely leading to the expression of p17 along with the CP and
lending support to the hypothesis that p17 may function as a viral
RNA packaging factor.
To investigate the inﬂuence of p17 expression on vRNA2 packa-
ging, HaSV VLPs were puriﬁed from insect cells transfected with
pMV18 (full length RNA2), pMV20 (shortened leader sequence but
including p17 and p71) and pMV26, which has a truncated leader
sequence with the start of the p17 CDS deleted, expressing only p71
(Fig. 4A). There were no signiﬁcant differences between the VLPs
generated from each of these constructs and their surface morphol-
ogies were indistinguishable from the wild-type virus particles with
the particle diameters ranging from 38 to 40 nm (Fig. 4B). Some
smaller and larger apparently malformed particles were present in all
the VLP samples (data not shown). There was no signiﬁcant difference
between the average diameters of VLPs assembled in the presence of
p17 (pMV18 and pMV20) and those without p17 (pMV26).
Analysis of encapsidated RNA puriﬁed from equivalent amounts
of VLPs showed, in contrast to wild-type virus, the absence of clearly
deﬁned bands corresponding to the CP transcripts in the VLPs
(Fig. 4C, lane 1 vs. lanes 2, 3 and 6). This was also the case for VLPs
assembled in cells transfected with pMV27 (expressing p17 and p71
with a truncated 30 UTR) and pMV28 (truncated 50 UTR, truncated 30
UTR, but expressing both p17 and p71) (Fig. 4C, lanes 4 and 5). Using
northern analysis with probes directed against RNA2, two RNA
species were detected in VLPs puriﬁed from cells transfected with
pMV18; one with a relative size that corresponded to vRNA2 and
another larger species of approximately 3.6 kb (Fig. 4C, lane 8), which
is the predicted size of the mRNA transcript that would be obtained
prior to cleavage at its 30 terminus by the HC ribozyme. These RNA
bands were also present in VLPs puriﬁed from cells transfected with
pMV20, pMV27 and pMV28 (Fig. 4C, lanes 9–11), but not in VLPs
assembled in cells expressing only p71 (Fig. 4C, lane 12). The
intensity of the RNA2 signals indicate that the amount of packaged
vRNA relative to cellular RNA is relatively small, consistent with the
observations of Routh et al. (2012). These results demonstrate,
however, that packaging of RNA2 into VLPs increases when the p17
ORF, and potentially p17 are present during capsid assembly. Inter-
estingly, different proportions of the two RNA species (cleaved and
uncleaved) were packaged in VLPs puriﬁed from pMV18 and pMV20-
transfected cells, even though the same ribozyme was used (Fig. 4C,
Table 2
Recombinant plasmids and baculoviruses used for expression studies in Spodoptera frugiperda Sf9 tissue culture cells.
Recombinant plasmids
Construct Parent vector Promoter RNA2 insert ORFs Kozak* Ribozyme
pMV17 – PAcMNPV 1–2478 p17 p71 AUUUAUGA CAGGAUGG Yes
pMV18 pMV17 Phr:AcMNPV 1–2478 p17 p71 AUUUAUGA CAGGAUGG Yes
pMV19 pMV17 PAcMNPV 246–2478 p17 p71 AUUUAUGA CAGGAUGG Yes
pMV20 pMV18 Phr:AcMNPV 246–2478 p17 p71 AUUUAUGA CAGGAUGG Yes
pMV21 pMV20 Phr:AcMNPV 246–756 2096–2478 p17 AUUUAUGA Yes
pMV24 – Phr:AcMNPV 280–756 p17 CAAAAUGA1 No
pMV25 pMV24 Phr:AcMNPV 283–756 p17 CUUUAUGA No
pMV26 pMV18 Phr:AcMNPV 366–2306 p71 CAGGAUGG No
pMV27 pMV18 Phr:AcMNPV 1–2306 p17 p71 AUUUAUGA CAGGAUGG No
pMV28 pMV18 Phr:AcMNPV 246–2306 p17 p71 AUUUAUGA CAGGAUGG No
pAM10 pMV18 Phr:AcMNPV 1–2478 p71 UGAUGATA CAGGAUGG Yes
Recombinant baculoviruses
Construct Parent vector Promoter RNA2 insert ORFs
VCAP Bac-to-Bac polH 1–2478 p71
AM20 FASTBac-Dual p10 1–2478 (pMV18) p17, p71
AM21 FASTBac-Dual p10 1–2478 (pAM10) p71
AM23 AM20 p10 polH 1–2478 (pMV18) 280–756 p17, p71 p17
AM24 AM21 p10 polH 1–2478 (pAM10) 280–756 p71 p17
JRS53 AM21 p10 polH 1–2478 (pAM10) Synthetic p17 cds p71 p17
n Native or mutated start codon underlined; Wild-type viral Kozak for p17: AUUUAUGA; wild type viral Kozak for p71: CAGGAUGG; 1 Consensus Kozak for
invertebrates (9).
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lanes 8 and 9). This may be due to the absence of the 50 UTR in
pMV20, however, since there is some variability in the ratio of RNAs
in VLPs assembled from the same plasmid (compare Fig. 4C, lane 8 to
Fig. 4D, lane 5), a more likely explanation is that the relative amount
of each species packaged is dependent upon the total cellular pool of
cleaved and uncleaved RNA2 at the time of assembly.
The data presented thus far support the hypothesis that p17 plays
a role in the packaging of HaSV vRNA2, but does not exclude the
possibility of a cis-acting sequence present in the p17 CDS. Accord-
ingly, cells were transfected with a construct (pAM10) carrying the
full length HaSV vRNA2, but with a mutation in the AUG start codon
of p17 (pAM10, Table 2 and Fig. 4A). As observed before, two RNA2
transcripts, corresponding to vRNA2 and the uncleaved mRNA were
present in VLPs from cells transfected with pMV18, which expresses
wild-type RNA2 (Fig. 4D, lane 5). However, VLPs derived from cells
transfected with pAM10 did not package vRNA2 (Fig. 4D, lane 6)
suggesting that translation of p17 was required for the encapsidation
of viral RNA2. We were unable to detect p17 in any VLPs.
P17 expression and vRNA packaging by baculovirus-derived VLPs
To increase VLP production, a series of recombinant baculo-
viruses, co-expressing vRNA2 and p17 were constructed using the
FastBac Dual system (Supplementary data Fig. S1) allowing for the
simultaneous expression of two transcripts under control of the
p10 and polH baculoviral promoters. Western analysis of cell-free
extracts detected p17 expression by the recombinant baculo-
viruses, despite the poor, native Kozak sequence (Compare Fig. 5,
lane 3 with Fig. 3B, lane 1, with baculovirus vs. plasmid expression
of vRNA2, respectively). Increased levels of p17 expression were
detected in cells infected with AM23 (Fig. 5, lane 5), which
expresses a p17-encoding mRNA in addition to RNA2. p17 was
also produced by the JRS53 baculovirus (data not shown). No p17
was detected in cells infected with the AM21 baculovirus, which
carries the mutated p17 UAG start codon (Fig. 5, lane 4) but the
protein was present in cells infected with AM24, which expresses
the p17 transcript in addition to the mutated RNA2 (Fig. 5, lane 6).
Northern analysis conﬁrmed the presence of p10-dervied
vRNA2 transcripts in baculovirus-infected cells (Fig. 6A, right
panel, lanes 4–8) and also a second, smaller polH-derived tran-
script, encoding only the p17 ORF, in cells infected with AM23 and
AM24 (Fig. 6A, right panel, lanes 7–8). RNA species corresponding
in size to vRNA2 and the RNA2 mRNA transcript prior to ribozyme
cleavage were present in VLPs derived from the AM20, AM21,
AM23 and AM24 baculoviruses (Fig. 6B, lanes 1–2, 4–5). A larger
RNA species was present in VCAP-derived VLPs, representing a
poly(A) CP mRNA, consistent with the absence of the HC ribozyme
in this construct (Fig. 6B, lane 3). The presence of vRNA2-derived
transcripts was detected in VLPs produced by all ﬁve baculovirus
constructs, irrespective of the presence or absence of p17 (Fig. 6D).
However, RNA corresponding to the polH-derived p17 sequence
was not detected (Fig. 6D, lanes 4–5), suggesting either that the
RNA was not packaged or that it was packaged at signiﬁcantly
lower levels than full length RNA2.
We next wanted to determine whether VLPs selectively pack-
aged only vRNAs expressing the CP (i.e. the p10-derived mRNA2
transcripts) or whether the polH-derived transcripts were also
packaged. Northern analysis using a probe directed against the
polH sequence in pFastBac Dual detected the polH transcript in
cells transfected with AM20 and AM21 (Fig. 7A, right panel, lanes
2–3). Also detected was the vRNA2 transcript, which cross-reacts
with common vector sequences in the probe. Northern analysis
did not detect a polH transcript in encapsidated RNA from AM20
and AM21 VLPs, but the cross-reaction between the probe and
vRNA2 transcripts prevented us from unequivocally demonstrat-
ing the absence of polH RNAs in the VLPs (data not shown). We
used RT-PCR analysis of packaged RNA to conﬁrm the presence of
p17-related sequences (within vRNA2) in wild-type HaSV particles
(Fig. 6B, lane 2) as well as in VLPs derived from AM20, AM21,
AM24 and JRS53 (Fig. 7B, top, lanes 4–7), but not in VLPs produced
by the VCAP baculovirus, which expresses only the CP ORF (Fig. 7B,
top, lane 3). VLPs derived from cells infected with JRS53 packaged
both the p10-derived vRNA2 and a pohH-derived RNA2 transcript
in which the p17 CDS has been replaced with a synthetic CDS that
produces a slightly larger RT-PCR product than the wild-type
sequence (Fig. 7B, top, lane 4). We were unable to detect any polH
transcripts in AM20 or AM21 VLPs (Fig. 7B, bottom), indicating
that this transcript is apparently excluded from VLPs, even though
it is relatively abundant in AM20 and AM21-infected cells (Fig. 7A,
right panel, lanes 2–3). Thus in this system, HaSV VLPs package
viral RNA2-encoding sequences, but in contrast to the plasmid-
based expression system, p17 does not appear to signiﬁcantly
affect the amount of encapsidated RNA2 packaged under condi-
tions of RNA excess (baculovirus expression).
Discussion
Structural and biophysical studies have provided a wealth of
information on the mechanics of tetravirus capsid assembly and
maturation, including evidence of close interactions between
Fig. 3. Regulation of p17 expression in Sf9 tissue culture cells. (A) The function of viral
50 UTR in regulation of p71 and p17 translation. The presence of CP (p71, p64) and p17
was detected by western analysis using anti-CP antibodies (top) or anti-p17 antibodies
(bottom). Crude protein extracts were derived from cells transfected with recombinant
plasmids with either the low level AcMNPV promoters (pMV17, pMV19) or high level
promoter (pMV18, pMV20 and pMV21). Expression plasmids pMV17 and pMV18 carry
the wild-type 50 UTR (wt 50 UTR) while pMV19, pMV20 and pMV21 (C-terminal region
of p71 ORF downstream of p17 CDS deleted) have a truncated 50 UTR (Δ 50 UTR).
(B) Western analysis of Sf9 cell-free extracts with p17 expressed from plasmids with
different 50 UTR and Kozak sequences. Lane 1: pMV18 which contains the wild type
viral RNA2 sequence; Lane 2: pMV19 carries a truncated 50 viral UTR; Lane 3: pMV25
has no viral 50 UTR but carries the wild type viral Kozak sequence; Lane 4: pMV24 has
no viral 50 UTR with an optimized Kozak; Lane 5: untransfected Sf9 cells (); Lane 6:
recombinant his-tagged p17 (His-p17). The intensity of a cellular protein that cross-
reacts with the anti-p17 antibodies (indicated with an asterisk) was used to ensure
equivalent loading of protein samples.
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packaged RNA and the internal domains of the tetravirus capsid
shell (Banerjee et al., 2010). However, nothing is known about how
omegatetraviruses select vRNA during virion assembly and the aim
of this study was to determine whether p17 was involved in this
process.
Although the p17 ORF is conserved across the omegatetra-
viruses, previous studies had not detected its expression during
infection. We were able to conﬁrm the initial hypothesis that p17
is also translated during active infection and that the levels of p17
expression seem to be carefully controlled at the level of transla-
tional initiation, where the poor context of the p17 start codon
ensures that p71 is made in vast excess, even though it is the
second ORF on the RNA2 (Fig. 3). While the role of the PEST related
sequences and potential ubiquitylation sites in the turnover of p17
in cells was not directly assessed in this study, it is our suggestion
that decreased expression from a poor Kozak sequence accounts
for the low levels of p17 detected in infected cells.
Having established that p17 was present during infection, we
set about investigating its role in the virus lifecycle. Our initial
hypothesis was that p17 was involved in the selection of vRNA for
encapsidation. A previous report designated a non-structural role
for p17 based on the observation that antiserum raised against
puriﬁed particles did not react with puriﬁed p17 by Western blot
(Hanzlik et al., 1995). Subsequent structural studies appeared to
validate this assumption since p17 was not detected in either cryo-
EM or X-ray crystallography reconstructions. However, due to the
lack of infectious experimental systems and the ease with which
VLPs self-assemble in vitro, these studies were typically conducted
using expression systems containing only the capsid protein ORF
(Canady et al., 2000; Taylor et al., 2002; Speir and Johnson, 2008).
This means that both signiﬁcant proportions of the wild-type
vRNA sequence and the ﬁrst ORF on RNA2 (p17) were removed,
ignoring their potential roles. In the only crystal structure of
authentic virus particles of NωV (Munshi et al., 1996; Helgstrand
et al., 2004), the density associated with p17 would have been lost
due to the effects of icosahedral averaging inherent in such studies
since we estimate that p17 is present at about 4–8 copies per
particle.
A recent study by Dent et al. (2013) demonstrates a similar
outcome in the case of the bacteriophage MS2 and its minor capsid
Fig. 4. RNA packaging by VLPs from plasmid-based expression systems. (A) Schematic representation of expression constructs with extent of RNA2 sequences and position of
p17 and p71 ORFs indicated. “HC” denotes the presence of a hairpin ribozyme cassette while the (n) indicates the start of the p17 ORF which has been mutated in pAM10.
(B) TEM micrographs of wild type HaSV particles and VLPs puriﬁed form Sf9 cells transfected with pMV18, pMV20 and pMV26. (C) Analysis of total RNA extracted fromwild
type virus particles and VLPs by denaturing agarose gel electrophoresis (Panel C, lanes 1–6) and Northern analysis with a probe detecting RNA2 (Panels C, lanes 7–12).
Molecular weight markers (MR) are indicated on the left in kb. (D) Analysis of RNA packaging by VLPs assembled in the absence of p17. VLPs were puriﬁed from cells
transfected with MV8 (wild-type RNA2) and pAM10 (AUG start codon of p17 mutated). The left-hand panel (lanes 1–3) shows SDS-PAGE analysis of wild-type virus and VLPs
while the right hand panel (lanes 4–6) shows the Northern blot used to detect RNA2 in RNA extracted from these VLPs (Lanes 1–3). RNA was extracted from equivalent
quantities of VLPs (left panel), normalized by estimating the concentrations using UV spectroscopy to ensure equivalent loading of VLP RNA, followed by northern analysis to
detect RNA2 (Lanes 5–6). Molecular weight markers (MR) for SDS-PAGE analysis are indicated to the left in kDa.
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protein, MP or maturation protein. In MS2, MP is packaged at a
rate of one copy per particle, is not required for capsid assembly
and is involved in receptor and RNA binding, but has remained
undetected in structural studies—a single copy being averaged out
during symmetrical averaging (Nathans et al., 1966; Shiba and
Suzuki, 1981; Krahn et al., 1972). Using low-resolution cryoEM
tomography of MS2 bound to its native receptor, a single copy of
MP was identiﬁed, replacing one of the CP dimers in the capsid
shell, underscoring the inherently asymmetrical nature of some
icosahedral particles. Icosahedral asymmetry has been observed in
other RNA viruses, such as a single covalent CP dimer in some
tombusviruses, an uncleaved capsid precursor is sometimes
included in picornaviruses capsids in addition to Vpg. The minor
VP2 protein in caliciviruses, which is present at an average of 1.5
copies per virion is, to our knowledge, the only other “packaged”
minor capsid protein in ssRNA viruses of animals (Stockley et al.,
1986; Dunker and Rueckert, 1971; Glass et al., 2000). It remains to
be seen how widespread and important such asymmetry is for
RNA viruses as a whole.
Taking into consideration that p17 is not required for VLP
assembly, but is present inside wild type virus particles and has
been shown to have RNA-binding capacity (in DpTV) (Zhou et al.,
2008), it is likely that p17 is important in either vRNA packaging
during assembly or RNA delivery upon infection. Although these
processes are not mutually exclusive, the limitations of current
experimental systems make it difﬁcult to study the role of p17 in
initiating infection. Analysis of the relative amount of RNA2
packaged into VLPs generated in either plasmid-based (low levels
of RNA2 and consequently p17 and CP) or recombinant baculovirus
Fig. 5. Baculoviral expression of p17 in Sf9 cells. Coomassie-stained SDS-poly-
acrylamide gel (top) showing relative quantities of crude protein and western
analysis (bottom) to detect p17 in Sf9 cells infected with recombinant baculo-
viruses. Lane 1: recombinant his-tagged p17; Lane 2: wild-type baculovirus ();
Lanes 3–6: recombinant baculoviruses carrying either RNA2 (AM20), RNA2 with
the AUG start codon of p17 mutated (AM21), RNA2 together with p17 (AM23) or
RNA2 with the AUG start codon of p17 mutated together with p17 (AM24).
Fig. 6. RNA packaging by VLPs assembled in Sf9 cells infected with recombinant baculoviruses co-expressing p17 and p71. (A) Agarose gel electrophoretic analysis of mRNA
expression in in Sf9cells infected with recombinant baculoviruses co-expressing p17 and p71. (B) Northern blot to detect the transcription of RNA2-derived sequences by
recombinant baculoviruses in Sf9 cells (Lanes 4–8). Lane 1: RNA extracted form wild-type HaSV; Lane 2: uninfected cells; Lane 3: cells infected with the wild-type
baculovirus. (C) Agarose gel electrophoretic analysis of RNA packaged by VLPs assembled in Sf9cells infected with recombinant baculoviruses co-expressing p17 and p71.
(D) Northern blot to detect RNA2-derived transcripts packaged by VLPs. The positions of RNA transcripts corresponding to wild type viral RNA (RNA2), RNA2 expressed by
recombinant baculoviruses (mRNA2) or mRNA corresponding to the p17 coding sequence (p17 mRNA) are indicated by arrows to the right of each image. The relative
molecular weights are indicated to the left (MR) in kb.
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(high levels of RNA2, p17 and CP) expression systems, produced
conﬂicting results. At low RNA and CP levels, p17 had a positive
effect on RNA2 encapsidation, increasing the amount of vRNA
puriﬁed from VLPs to detectable levels (Fig. 4). However, in the
baculovirus expression system RNA2 was observed both in the
presence and absence of p17 (Fig. 6). We have been unable to
detect p17 in VLPs generated from either system (data not shown).
Based on the assumption that the rate of p17 inclusion in wild type
HaSV particles is constant, it would be logical to deduce that either
p17 is not present in the VLPs at all or that it is co-packaged only in
a sub-population. The increase in RNA2 encapsidation in the
plasmid-based expression system in the presence of p17 suggests
that the latter option is more likely to be the case.
We therefore propose that, due to inefﬁciencies inherent in
these heterologous systems (discussed below), co-expression of
p17 with RNA2 results in the generation of at least two popula-
tions of particles: population A without p17 that packages RNA
indiscriminately depending on the surrounding cellular levels and
population B, consisting of virions that all contain a copy of RNA2
and p17 (Fig. 8). In the low-level expression system, the indis-
criminate packaging of RNA2 in the absence of p17 is too low
relative to the amount of cellular mRNA to detect by northern
analysis. The addition of p17 generates the second population that,
by virtue of consistently and actively including RNA2, increases the
total amount of RNA2 in the population above the limit of
detection. Since the cytoplasmic levels of RNA2 generated in the
baculovirus expression system are already relatively high, non-
discriminate packaging in the absence of p17 is sufﬁcient for
detection of RNA2 in population A alone. The addition of p17
merely increases the rate of RNA2 incorporation, but this change is
undetectable due to the high level of RNA2 already being packaged
at random. This model, however, does not account for the
apparent absence of the polH baculoviral transcript from puriﬁed
VLPs (Fig. 7B).
We are, however, cautious about extending this hypothesis to
the in vivo conditions present during active viral infection, since a
number of inefﬁciencies are present in the systems we have
applied here. First, these experiments were all performed without
the assistance of active viral infection, which has been shown to be
essential for packaging ﬁdelity in a number of viruses including
Poliovirus, Brome mosaic virus and the structurally related noda-
viruses (Nugent et al., 1999; Annamalai et al., 2008; Venter et al.,
2005). Second, the larger, viral RNA1 is entirely absent from both
systems. This is likely to have a signiﬁcant impact on the efﬁciency
Fig. 7. Packaging of non-viral RNA by VLPs. (A) Detection of polHmRNA in Sf9 cells.
Left: Agarose gel electrophoretic analysis of cellular RNAs in cells infected with
recombinant baculoviruses expressing wild-type RNA2 (Bac20), RNA2 with the
AUG start codon of p17 mutated (Bac21), and only the p71 coding sequence (VCAP).
AcMNPV: wild type baculovirus; (): uninfected cells; HaSV: wild type HaSV
particles. Right: Northern blot to detect polH-related transcripts. (B) RTPCR analysis
of packaged viral RNAs to detect transcripts carrying p17-coding sequences (top) or
polH-derived transcripts (bottom). Lane 1: no template (); Lanes 2–7: RNA
extracted from wild type virus (HaSV), or VLPs derived from cells infected with
VCAP, JRS53, AM20, AM21 or AM24. Lane 8: PCR control reaction using plasmids
used to generate recombinant baculoviruses the cloning vector pFastBac Dual
(pFASTBac-Dual) or JRS53 (pJRS53).
Fig. 8. Schematic representation of proposed RNA and p17 packaging proﬁles of HaSV VLPs produced by plasmid- (low level) and baculovirus-derived (high level) expression
system. CP: capsid protein; cRNA: cellular mRNAs and rRNAs; vRNA: HaSV RNA2.
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of packaging in general and is the subject of active ongoing
research within our group. Finally, a recent study into the packa-
ging dynamics of satellite tobacco necrosis virus suggests that the
CP-induced collapse of gRNA into its ﬁnal condensed and struc-
tured form is signiﬁcantly affected by higher CP concentrations
(see discussion in Ford et al., 2013).
Conclusions
The data presented here clearly establishes that p17 is
expressed in infected cells and that it is co-packaged in wild type
virions making this one of very few such examples in ssRNA
viruses of animals. While not conclusive, our results are suggestive
of at least some role for p17 in the speciﬁc packaging of RNA2,
possibly as a packaging factor—a class of protein typically assumed
to be limited to bacteriophages. In addition to exploring new
opportunities for creating experimental systems that support
HaSV infection, research is currently underway to gain further
insight into this potential role by studying the impact of introdu-
cing RNA1 into these systems.
Materials and methods
Virus preparation and detection of p17 expression
Second or third instar H. armigera larvae were droplet-fed
approximately 1106 HaSV particles, reared as previously
described (Christian et al., 2001) and harvested after 8–10 days.
Wild-type virus was produced from HaSV-infected larvae essen-
tially according to previously described methods (Hanzlik et al.,
1993). The virus was puriﬁed by ultracentrifugation through a 30%
sucrose cushion at 100 000 g for 3 h, followed by sucrose
gradient density ultracentrifugation using a 10% 40% sucrose
gradient (w/v) at 140 000 g for 75 min. Gradient fractions con-
taining virus were pooled and pelleted by ultracentrifugation for
3.5 h at 100 000 g. The ﬁnal virus pellet was re-suspended
overnight in 50 mM Tris buffer (pH 7.4) at 4 1C and stored at
20 1C in 20% glycerol (v/v).
Expression of p17 was detected by western analysis of crude
protein extracts of midgut tissue dissected from infected
H. armigera larvae, transfected S. frugiperda Sf9 cells or wild-type
virus particles, using anti-p17 rabbit polyclonal antibodies (diluted
1:170 000) raised against recombinant 6xhis-tagged p17 produced
in Escherichia coli BL21 (DE3) cells. Cell-free extracts of larval
midgut tissue were produced by homogenizing 30 mg of tissue in
2 ml E buffer (40 mM Tris-Acetate, 2 mM Na2EDTA, pH 7.4)
containing Roche Complete Protease Inhibitor with acid-washed
glass beads, followed by centrifugation at 10 000 g for 20 min at
4 1C to pellet cellular debris.
Dissociation study using 4 M guanidine hydrochloride
Puriﬁed, fully matured wild-type HaSV particles were incu-
bated in DLS buffer (25 mM NaOAc pH5.0; 125 mM NaCl; 0.5 mM
Na2EDTA; 40 mM DTT) containing 4 M guanidine hydrochloride
(GdnHCl) and then washed ﬁve times with 300 μl of the DLS-
GdnHCl buffer using either Ultrafree 100 kDa NWCO Amicon ultra-
4 centrifugal ﬁlters (Millipore) to remove dissociated proteins.
Particles were exposed to 4 M GdnHCl for 2–3 h during each wash
step. Thereafter the DLS-GdnHCl buffer was replaced with DLS
buffer lacking GdnHCl and the particles were re-concentrated.
Lysozyme (14.3 kDa) was used as a control for DLS studies and we
conﬁrmed that approximately 99% of the lysozyme was efﬁciently
removed by the same procedure (data not shown).
Co-expression of p71 with viral RNA in insect cells and VLP
puriﬁcation
Plasmid-based expression
Two promoter systems were used for plasmid-based expres-
sion of p17 and p71 in S. frugiperda Sf9 cells. The AcMNPV and hr:
AcMNPV promoters are both derived from the Autographa califor-
nica nucleopolyhedrovirus (AcNMPV) multicapsid promoter and
provide low and high levels of transcription, respectively (Ayers
et al., 1994). Recombinant plasmids used for expression experi-
ments in Sf9 cells are listed in Table 2. The construct pMV17 carries
the full HaSV RNA2 cDNA sequence downstream of PAcMNPV,
followed by a hairpin cassette ribozyme, the SV40 origin of
replication and a kanamycin/neomycin resistance selectable mar-
ker. In pMV18 PAcMNPV has been replaced with Phr:AcMNPV to
facilitate high level transcription of RNA2. Plasmids pMV19–21
and pMV26–28 are all derivatives of pMV17 or pMV18 fromwhich
sequences within the 50 and/or 30 untranslated regions of RNA2
have been deleted. The construct pAM10 is also a derivative of
pMV18, where the p17 start codon (AUG AGC) has been mutated to
(GAT ATC), encoding a diagnostic Eco RV restriction site, thus
silencing the p17 ORF. Construct pMV25 carries only the p17 cDNA
coding sequence including a native Kozak sequence downstream
of Phr:AcMNPV while pMV24 is the same as pMV25 except that the
Kozak sequence has been optimized for expression in
invertebrate cells.
For expression of p17 and p71, conﬂuent monolayers of Sf9 cells
(1.8105) were transfected with 200 ng of the appropriate plas-
mid using Fugenes HD (Roche) and cultured in TC100 complete
insect culture medium (Cambrex) containing 10% foetal bovine
serum, 100 U ml1 penicillin and 10 mg ml1 streptomycin (v/v)
for 3 days at 28 1C. The transfected cells were harvested and used
for western analysis and/or VLP puriﬁcation. For VLP puriﬁcation,
four T75 ﬂasks of cells were lysed with 0.5% NP-40 and after
15 min shaking at room temperature, the cell debris was pelleted
by centrifugation at 10 000 g for 20 min at 4 1C. VLPs were then
pelleted by centrifugation at 100 000 g for 3.5 h at 4 1C through a
30% sucrose cushion (w/v) prepared in 50 mM sodium acetate
(pH 5.0), 250 mM NaCl and 5 mM EDTA. VLP pellets were resus-
pended overnight at 4 1C in approximately 100 ml 50 mM Tris
(pH 7.4).
Baculoviral expression
A series of recombinant baculoviruses expressing p17 and/or p71
were constructed using the FASTBac-Dual vector (Invirogen) system
(Table 2; Supplementary data, Fig. S1). The VCAP baculovirus
(obtained from Jack Johnson, Department of Molecular biology,
The Scripps Institute), which contains the HaSV p71 coding
sequence downstream of an optimized Kozak cloned into the
pVL941 vector (Pharmingen), was used to generate the recombinant
baculovirus (VCAP) in S. frugiperda Sf9 cells (35). Recombinant
baculoviruses AM20 and AM21 carry HaSV RNA2, but in AM21,
the AUG start codon of the p17 ORF is mutated (equivalent construct
to pAM10). The recombinant baculoviruses AM23 and AM24 are the
same as AM20 and 21 with respect to their RNA2 inserts, but they
co-express p17 from a copy of the p17 CDS in its native translation
context, downstream of the polH promoter. Baculovirus JRS53 is
derived from AM21, but carries a full length copy of the vRNA2 in
which the viral sequences encoding p17 have been replaced by a
synthetic CDS that still encodes native p17, but not the start of the
p71 ORF, expressed under control of the polH promoter. This
construct expresses p71 and p17 in the p10 and polH directions,
respectively, from two full-length RNA2 transcripts, but with the
polH-derived transcripts carrying a synthetic p17 CDS (Table 2;
Supplementary data, Fig. S1).
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Baculovirus infections were carried out essentially according to
the manufacturer’s instructions (Bac-to-Bac Baculovirus Expres-
sion System, Invitrogen). Approximately 1.4 107 Sf9 cells were
seeded into each of two T75 ﬂasks, which were infected with the
recombinant baculoviruses at an MOI of 5.0 and incubated for
4 days. A protocol adapted from Taylor et al. (2002) and Bothner
et al. (2005) was used to purify VLPs from the baculovirus-infected
insect cells. NP-40 at a concentration of 0.5% (v/v) was added
directly to each ﬂask, which was left to shake on ice for 15 min.
Cellular debris was pelleted by centrifugation at 10 000 g for
20 min at 4 1C and the VLPs were pelleted through a 30% (w/v)
sucrose cushion, prepared in sodium acetate buffer (50 mM
sodium acetate; 250 mM NaCl; 5 mM Na2EDTA, pH 5.0), by
ultracentrifugation at 100 000 g for 4 h at 4 1C. The resulting
VLP pellets were resuspended overnight at 4 1C in approximately
100 ml of the sodium acetate buffer and further puriﬁed via sucrose
gradient ultracentrifugation (10–40% w/v) for 90 min at
140 000 g. The VLPs were concentrated by a ﬁnal ultracentrifu-
gation step at 140 000 g for 4 h at 4 1C and the resulting pellets
resuspended in 100 ml sodium acetate buffer and stored at 20 1C.
Transmission electron microscopy
VLPs and wild-type virus particles were prepared for transmis-
sion electron microscopy (TEM) using a previously described
method (Dong et al., 1998). Approximately 5 ml of the virus or
VLP sample was applied to a glow-discharged copper grid stained
with 1% uranyl acetate solution and viewed at 100 kV using a JOEL
JEM-1210 transmission electron microscope.
RNA extraction, northern and RT-PCR analysis
RNA was puriﬁed from wild-type virus or HaSV VLPs according
to previously described protocols (Venter et al., 2005). Approxi-
mately 1–2 μg of total RNA was used for northern analysis. Viral
RNA was detected using a DIG–UTP-labelled antisense probe
corresponding to nts 366–2309 of HaSV RNA2. Hybridisation and
autographic detection was carried out using the DIG High Prime
DNA Labeling and Detection Starter Kit II according to the
manufacturer’s instructions (Roche). RT-PCR detection of synthetic
p17-containing transcripts in packaged RNA was conducted using
primers JRS56F (CGG TTC TGA ACA TCG GAA AGG), JRS58R (GCC
TCT GGC TCC GGA GGG), while transcripts carrying the authentic
p17 sequence were detected using primers JRS56F and JRS59R
(GGA GTG GGC GAT GGT GTG CTC), all in the same reaction. JRS56F
binds upstream of the p17 start codon (binds to both wild-type
and synthetic RNA) while JRS58R and JRS59R bind to the region
within the p17 sequence upstream of the p71 start in the synthetic
and wild-type p17 sequences, respectively. The expected sizes of
the RT-PCR products are 165 bp for the JRS56F and JRS59R (wild-
type) and 218 bp for JRS56F and JRS58R (synthetic p17 gene)
primer combinations. The polH RT-PCR reactions were done using
primers AM18 (ATT CAT ACC GTC CCA CCA TCG GG) and JRS61 (CTC
TAG TAC TTC TCG ACA AGC TTG TCG AG). AM18 and JRS61 bind on
either side of the predicted mRNA that is produced from the polH
promoter in pFastBac Dual, producing an RT-PCR product of
141 bp.
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